Pre-Pandemic Vaccines Should Meet Normal Vaccine Approval Bar – Cmte
Executive Summary
Vaccines intended for pre-pandemic use should be held to a significantly higher safety and efficacy standard than those intended for use during a pandemic, members of FDA's Vaccines & Related Biological Products Advisory Committee said during a Feb. 27 meeting